Skip to main content

Table 2 Change of parameters

From: Dipeptidyl peptidase 4 inhibitor linagliptin can decrease the dosage of erythropoiesis-stimulating agents in patients on hemodialysis

  Before treatment Post treatment Wilcoxon signed-rank test
Dosage of DA 23.9 ± 21.2 11.3 ± 9.7 P < 0.05
ERI 2.27 ± 2.08 1.04 ± 0.90 P < 0.05
Hb 10.8 ± 0.6 11.4 ± 0.9 NS
hs-CRP 5335 ± 6495 2568 ± 4059 NS
TSAT 24.2 ± 6.5 31.9 ± 11.0 NS
Ferritin 264.7 ± 334.6 249.8 ± 224.2 NS
Albumin 3.6 ± 0.4 3.6 ± 0.3 NS
WBC 5789 ± 1282 5687 ± 2121 NS
Plt 15.6 ± 6.4 15.2 ± 6.1 NS
  1. DA darbepoetin alfa, ERI erythropoiesis-stimulating agent-resistant index, Hb hemoglobin, TSAT transferrin saturation, WBC white blood cells count, Plt platelet count